ArabFinance: The ordinary general meeting (OGM) of Ibnsina Pharma (ISPH) has approved the board of directors’ proposal to pay cash dividends worth EGP 112 million, equivalent to EGP 0.10 per share, to shareholders for the full year ended December 31st 2021, according to a statement filed to the Egyptian Exchange on April 12th.

It is worth noting that the company’s consolidated net profit attributable to the holding company stood at EGP 314.72 million in 2021, up from EGP 224.66 million in 2020.

Ibnsina is an Egypt-based pharmaceutical distribution company, with a diversified portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers.